Post Reply
1 of 1
India variant responds to Pfizer vacinne
2,630 Views |
7 Replies |
Last: 4 yr ago by Windy City Ag
Good news. Would have been terrible to hear otherwise, but this provides some reassurance that unvaccinated people won't trigger a new wave of disease...at least not yet.
94chem,
That, sir, was the greatest post in the history of TexAgs. I salute you. -- Dough
That, sir, was the greatest post in the history of TexAgs. I salute you. -- Dough
My friends in India say it's bad. Very difficult to get vaccine from government at $50 and black market has it for 10x that. Why is it so easy to get and free in the US?
rynning said:
Why is it so easy to get and free in the US?
Our government (Trump's administration) pre-purchased millions of doses before the vaccine was even finished.
Oh, yeah. I almost forgot.BrazosWifi said:rynning said:
Why is it so easy to get and free in the US?
Our government (Trump's administration) pre-purchased millions of doses before the vaccine was even finished.
rynning said:
My friends in India say it's bad. Very difficult to get vaccine from government at $50 and black market has it for 10x that. Why is it so easy to get and free in the US?
The fed prospectively purchased millions of doses from Pfizer and Moderna last fall while it was still under development, and has since partnered with multiple private distribution networks to facilitate widespread access quickly.
No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. See full Medical Disclaimer.
rynning said:
My friends in India say it's bad. Very difficult to get vaccine from government at $50 and black market has it for 10x that. Why is it so easy to get and free in the US?
You can thank Trump for that.
The Trump Admin definitely deserves credit for accelerating time to market, but there is a lot more at work than that including:
1) The U.S. Biotech and Pharma industry is the envy of the world
2) Because of that our country had the researchers and firms that came up with the vaccine concept that others had to piggy back off of.
3) We had the first world budgetary freedom to toss billions into a potential write-off of a project. Most third world countries don't
4) We were able to prioritize our own population prior to exporting vaccines.
5) Finally I did a lot of work in India and the country is a creaking, bureaucratic nightmare. I remember being told our local back office/data center needed no less than three telco providers because two of them go down at any given moment.
The government there has been Clay Jenkins on steroids regarding the vaccine rollout. It is one bureaucratic screw up after another.
1) The U.S. Biotech and Pharma industry is the envy of the world
2) Because of that our country had the researchers and firms that came up with the vaccine concept that others had to piggy back off of.
3) We had the first world budgetary freedom to toss billions into a potential write-off of a project. Most third world countries don't
4) We were able to prioritize our own population prior to exporting vaccines.
5) Finally I did a lot of work in India and the country is a creaking, bureaucratic nightmare. I remember being told our local back office/data center needed no less than three telco providers because two of them go down at any given moment.
The government there has been Clay Jenkins on steroids regarding the vaccine rollout. It is one bureaucratic screw up after another.
To this specific question, India's federal government did not ramp up purchasing and local manufacture of the vaccine like we did. They also decided to let smaller regional governments and private parties bid against them for international supply. This has resulted in the vaccine stock trickling in to private parties at greater prices and they in turn have engaged in selective pricing.Quote:
My friends in India say it's bad. Very difficult to get vaccine from government at $50 and black market has it for 10x that. Why is it so easy to get and free in the US?
Good read.
https://www.bbc.com/news/world-asia-india-56912977
Quote:
Until now, India's federal government had been the sole purchaser of the two approved vaccines - Covishield, developed by AstraZeneca with Oxford University and manufactured by SII; and Covaxin, made by a local firm Bharat Biotech.
But it's now thrown open the market to not just 28 state governments, but also private hospitals, all of whom can directly negotiate and buy from the two vaccine makers. And they have to pay far more.
The federal government still gets 50% of stocks for 150 rupees ($2; 1.40) per dose, but states have to pay double that, and private hospitals eight times as much - all while competing for the remaining half.
The sudden transfer of responsibility - it was announced just 10 days ago - left officials with little time to negotiate prices or stockpile vaccines. Especially since vaccine makers still have orders pending from the federal government.
"We are the only country in the world that is allowing sub-national governments to directly buy from vaccine makers. This is not at all well thought-out," says Mr Mukhopadhyay.
The different prices are concerning, says Srinath Reddy, a public health expert who advises federal and state governments on tackling Covid-19.
"All vaccination should be free, it's for public good," he says. "And why should states pay a higher price? They are also using tax payer money." He fears that it's now a "seller's market", where the poorest Indians are likely to be last in line.
Featured Stories
See All
10:14
1d ago
7.7k
Zach Clemence leads Texas A&M's 3-point barrage vs. South Carolina
by Olin Buchanan
5 Thoughts: Texas A&M 92, South Carolina 69
by Luke Evangelist
5:03
1d ago
2.0k
Game Highlights: Texas A&M 92, South Carolina 69
by Reece Nygren
Skid reaches four as Texas A&M falls at Mizzou, 81-70
by Justin Paez